17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

Details for Australian Patent Application No. 2002326823 (hide)

Owner Schering Corporation

Inventors Rivera, Jocelyn D.; Girijavallabhan, Viyyoor M.; Saksena, Anil K.; Paruch, Kamil; Pachter, Jonathan; Liu, Yi-Tsung; Doll, Ronald J.; Mallams, Alan K.; Guzi, Timothy J.

Agent Griffith Hack

Pub. Number AU-B-2002326823

PCT Number PCT/US02/28181

PCT Pub. Number WO2003/022835

Priority 60/317,715 06.09.01 US

Filing date 5 September 2002

Wipo publication date 24 March 2003

Acceptance publication date 15 December 2005

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/00 (2006.01) Antineoplastic agents

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/317,715 06.09.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002326823

15 December 2005 Application Accepted

  Published as AU-B-2002326823

13 April 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326824-SYSTEM AND METHOD FOR INTERFACING A WIRELESS TELEPHONE TO A PERSONAL COMPUTER

2002326822-PRO-MICELLE PHARMACEUTICAL COMPOSITIONS